Cameron (CAM) (PCS) (PKI) (PNR) (BRCM) (BPAX) Ratings, Price Targets

Cameron International (CAM), MetroPCS (PCS), PerkinElmer, Inc. (PKI), Pentair, Inc. (PNR), Broadcom Corp. (BRCM) and BioSante Pharmaceuticals, Inc. (BPAX) ratings and price targets.

Mizuho upgraded MetroPCS (PCS) from a “Neutral” rating to a “Buy” rating. They have a price target of $10.50 on the company, up from $8.50.

Goldman Sachs (NYE:GS) upgraded PerkinElmer, Inc. (PKI) from a “Neutral” rating to a “Buy” rating.

Wedbush raised its price target on Pentair, Inc. (PNR) to $47.00.

Wells Fargo & Co. (NYSE:WFC) upgraded Broadcom Corp. (BRCM) from a
“Market Perform” rating to an “Outperform” rating.

JMP Securities downgraded BioSante Pharmaceuticals, Inc. (BPAX) from an “Outperform” rating to a “Market Perform” rating.

Bank of America (NYSE:BAC) lowered its price target on Cameron International (CAM) to $71.00.